.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Federal Trade Commission
UBS
Deloitte
Express Scripts
Cipla
Healthtrust
Johnson and Johnson
Fish and Richardson

Generated: December 14, 2017

DrugPatentWatch Database Preview

Pohl Boskamp Company Profile

« Back to Dashboard

What is the competitive landscape for POHL BOSKAMP, and what generic alternatives to POHL BOSKAMP drugs are available?

POHL BOSKAMP has three approved drugs.

There are two US patents protecting POHL BOSKAMP drugs.

There are seventeen patent family members on POHL BOSKAMP drugs in nine countries.

Summary for Pohl Boskamp

International Patents:17
US Patents:2
Tradenames:5
Ingredients:1
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Pohl BoskampNITRONALnitroglycerinINJECTABLE;INJECTION018672-001Aug 30, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pohl BoskampGONITROnitroglycerinPOWDER;SUBLINGUAL208424-001Jun 8, 2016RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Pohl BoskampNITROLINGUAL PUMPSPRAYnitroglycerinSPRAY, METERED;SUBLINGUAL018705-002Jan 10, 1997ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Pohl BoskampNITRO IVnitroglycerinINJECTABLE;INJECTION018672-002Aug 30, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pohl BoskampNITROLINGUALnitroglycerinAEROSOL;SUBLINGUAL018705-001Oct 31, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Pohl Boskamp

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pohl BoskampNITROLINGUAL PUMPSPRAYnitroglycerinSPRAY, METERED;SUBLINGUAL018705-002Jan 10, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for POHL BOSKAMP drugs

Drugname Dosage Strength Tradename Submissiondate
nitroglycerinSublingual Spray400 mcg/spray, 4.9 g and 12 g bottlesNITROLINGUAL PUMPSPRAY8/23/2012
nitroglycerinSublingual Spray400 mcg/spray, 4.9 g and 12 g bottlesNITROLINGUAL PUMPSPRAY4/17/2012

Non-Orange Book Patents for Pohl Boskamp

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,616,023Stabilized granules containing glyceryl trinitrate► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Pohl Boskamp Drugs

Country Document Number Estimated Expiration
Australia2012219925► Subscribe
Canada2827716► Subscribe
European Patent Office2678000► Subscribe
BrazilPI0908577► Subscribe
Canada2718345► Subscribe
European Patent Office2678006► Subscribe
World Intellectual Property Organization (WIPO)2012113563► Subscribe
Canada2827714► Subscribe
European Patent Office2254552► Subscribe
Germany202008007318► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Covington
Boehringer Ingelheim
Farmers Insurance
UBS
US Department of Justice
Citi
Accenture
Chinese Patent Office
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot